Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study
Clinical trial NCT03919253 · UNKNOWN
Trial details
- NCT number
- NCT03919253
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-30
- Primary completion
- 2020-04-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.